Comparison between Thaai Casting IPO and Zenith Drugs IPO.
Thaai Casting IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
| Thaai Casting IPO | Zenith Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Thaai Casting IPO is up to ₹44.52 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Thaai Casting IPO is ₹77.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| Thaai Casting IPO | Zenith Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹73.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹77.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹77.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 57,82,400 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹44.52 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,82,400 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹44.52 Cr | up to ₹33.94 Cr |
Thaai Casting IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Thaai Casting IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.
| Thaai Casting IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Feb 14, 2024 | Feb 16, 2024 |
| Issue Open | Feb 15, 2024 | Feb 19, 2024 |
| Issue Close | Feb 20, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 21, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Feb 21, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Feb 22, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Feb 23, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | Mar 21, 2024 | Mar 24, 2024 |
| Anchor Lockin End date 2 | May 20, 2024 | May 23, 2024 |
Thaai Casting IPO P/E ratio is 25.99, as compared to Zenith Drugs IPO P/E ratio of 18.4.
| Thaai Casting IPO | Zenith Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Thaai Casting Ltd Financial Information (Restated Standalone)Thaai Casting Ltd's revenue increased by 27.84% and profit after tax (PAT) rose by 336.49% between the financial year ending with March 31, 2023 and March 31, 2022.
| Zenith Drugs Limited Financial Information (Restated Consolidated)Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 86.50 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 25.99 | 18.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹178.10 Cr. | ₹135.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 35.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13% | 37.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.85 | 1.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.96 | ₹4.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.10% | 29.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Thaai Casting IPO Retail Individual Investors (RII) are offered 20,24,000 shares while in Zenith Drugs IPO retail investors are offered 20,24,000 shares. Qualified Institutional Buyers (QIB) are offered 11,55,200 shares in Thaai Casting IPO and 8,59,200 shares in Zenith Drugs IPO.
| Thaai Casting IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Investor Reserveration | 17,34,400 shares | 12,88,000 shares |
| Market Maker Reserveration | 3,47,200 shares | 8,52,800 shares |
| QIB | 11,55,200 shares | 8,59,200 shares |
| NII | 8,68,800 shares | 6,44,800 shares |
| RII | 20,24,000 shares | 15,04,000 shares |
| Employee | ||
| Others | ||
| Total | 57,82,400 shares | 42,96,000 shares |
Thaai Casting IPO subscribed 375.43x in total, whereas Zenith Drugs IPO subscribed 179.18x.
| Thaai Casting IPO | Zenith Drugs IPO | |
|---|---|---|
| QIB (times) | 144.43x | 106.72x |
| NII (times) | 729.72x | 368.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 355.66x | 139.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 375.43x | 179.18x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
